Dr. Wieland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2485 Hospital Dr
Suite 200
Mountain View, CA 94040Phone+1 650-988-7480Fax+1 650-988-7482
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 1989 - 1990
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1986 - 1989
- University of California (San Francisco)Internship, Internal Medicine, 1985 - 1986
- Case Western Reserve University School of MedicineClass of 1985
Certifications & Licensure
- NY State Medical License 1989 - Present
- CA State Medical License 1990 - 2025
- PA State Medical License 1987 - 1989
- OH State Medical License 1985 - 1986
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation Start of enrollment: 2011 Feb 01
- Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept. Start of enrollment: 2013 Oct 01
- Intravitreal Gas for Vitreomacular Adhesion Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 169 citationsBrolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.Pravin U. Dugel, Glenn J. Jaffe, Peter Sallstig, James Warburton, Andreas Weichselberger
Ophthalmology. 2017-09-01 - 9 citationsImplant Insertion Procedure of the Port Delivery System With Ranibizumab: Overview and Clinical Pearls.Dante J Pieramici, Mark R Wieland, Jay M Stewart, Robert T Chang, Shamika A Gune
Ophthalmic Surgery, Lasers & Imaging Retina. 2022-05-01 - 8 citationsManagement of Key Ocular Adverse Events in Patients Implanted with the Port Delivery System with Ranibizumab.Carl C Awh, Giulio Barteselli, Sneha Makadia, Robert T Chang, Jay M Stewart
Ophthalmology. Retina. 2022-11-01
Press Mentions
- SUBSPECIALTY NEWS: Prophylactic Eylea, Combination Therapy for Wet AMD, Plasma Kallikrein Inhibitors, Bionic Eye, and MoreAugust 30th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: